BioCentury
ARTICLE | Distillery Therapeutics

Inflammation; endocrine/metabolic

August 16, 2018 4:12 PM UTC

In vitro and mouse studies identified a selective SGMS2 inhibitor that could help treat chronic inflammation and Type II diabetes. Chemical synthesis of benzoisoxazole analogs and in vitro enzyme acti...

BCIQ Company Profiles

Fudan University